Fortress Biotech (FBIO) Leases (2019 - 2025)
Historic Leases for Fortress Biotech (FBIO) over the last 7 years, with Q3 2025 value amounting to $12.3 million.
- Fortress Biotech's Leases fell 1293.81% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year decrease of 1293.81%. This contributed to the annual value of $13.9 million for FY2024, which is 1841.67% down from last year.
- Per Fortress Biotech's latest filing, its Leases stood at $12.3 million for Q3 2025, which was down 1293.81% from $12.8 million recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's Leases peaked at $20.1 million during Q1 2021, and registered a low of $12.3 million during Q3 2025.
- For the 5-year period, Fortress Biotech's Leases averaged around $17.1 million, with its median value being $18.0 million (2023).
- As far as peak fluctuations go, Fortress Biotech's Leases skyrocketed by 518.81% in 2022, and later crashed by 1918.96% in 2025.
- Quarter analysis of 5 years shows Fortress Biotech's Leases stood at $19.0 million in 2021, then rose by 5.19% to $20.0 million in 2022, then dropped by 15.01% to $17.0 million in 2023, then decreased by 18.42% to $13.9 million in 2024, then dropped by 11.11% to $12.3 million in 2025.
- Its Leases stands at $12.3 million for Q3 2025, versus $12.8 million for Q2 2025 and $13.3 million for Q1 2025.